Pharmafile Logo

B2B sales

- PMLiVE

Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients

Results of MANDALA trial will be presented at the American Thoracic Society (ATS) 2022 International Conference

- PMLiVE

MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients

The treatment, for Pseudomonas aeruginosa, will address a chronic and debilitating respiratory condition that has no approved available treatments

- PMLiVE

Shionogi and F2G partner to develop antifungal treatment olorofim

The deal, worth up to $480m, involves the first novel antifungal treatment developed in the last 20 years

- PMLiVE

Holistic Excellence

Why is it so hard to make your team or company excellent? Ask your Jeremiah

- PMLiVE

Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment

Plaque psoriasis is a chronic, systemic immune-mediated disease associated with multiple serious comorbidities

- PMLiVE

Scientists discover new approach to treat brain tumours

The results from the University of Surrey are from a seven-year research study on glioblastoma multiforme

Top 10 Creative Ways to Engage Your Advisors

At Impetus Digital, we pride ourselves with being the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight-synthesis. Our most popular service is online advisory boards. However, there is a myriad of...

Impetus Digital

AI in Healthcare: How to Accelerate Change

Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public...

Impetus Digital

- PMLiVE

5 steps to health content accreditation success

Accreditation for health content is a major way to set yourselves apart from your competitors, win exposure and new clients - find out what we wish we'd known when we...

Thrive Agency

- PMLiVE

Food Allergy – Is avoidance the only option?

Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...

IGNIFI

Serious about sustainability text on forest background

Serious about sustainability?

Get to know our new Sustainability Officer here at Cuttsy+Cuttsy

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links